1. Home
  2. MUX vs ZLAB Comparison

MUX vs ZLAB Comparison

Compare MUX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McEwen Mining Inc.

MUX

McEwen Mining Inc.

HOLD

Current Price

$19.45

Market Cap

1.6B

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$18.31

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MUX
ZLAB
Founded
1979
2013
Country
Canada
China
Employees
1432
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
MUX
ZLAB
Price
$19.45
$18.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
5
Target Price
$26.63
$49.60
AVG Volume (30 Days)
1.0M
681.4K
Earning Date
03-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.46
EPS
N/A
N/A
Revenue
N/A
$460,156,000.00
Revenue This Year
$22.52
$14.46
Revenue Next Year
$26.24
$29.47
P/E Ratio
N/A
N/A
Revenue Growth
N/A
15.33
52 Week Low
$6.38
$15.96
52 Week High
$29.70
$44.34

Technical Indicators

Market Signals
Indicator
MUX
ZLAB
Relative Strength Index (RSI) 34.24 45.50
Support Level $17.70 $17.03
Resistance Level $20.59 $19.49
Average True Range (ATR) 1.31 0.60
MACD -0.62 -0.16
Stochastic Oscillator 15.48 35.42

Price Performance

Historical Comparison
MUX
ZLAB

About MUX McEwen Mining Inc.

McEwen Inc, formerly McEwen Mining Inc is a mining and minerals production and exploration company that focuses on precious and base minerals in Argentina, Mexico, and the United States. The company generates its revenue from gold and silver production. It owns and operates the wholly-owned El Gallo 1 mine in Mexico and holds a minority stake in the company that manages the San Jose mine in Argentina. More than half of the company's gold output comes from the El Gallo 1 mine, while the remaining gold production and the majority of silver production are sourced from the San Jose mine. Geographically, majority of production occurs in the United States.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

Share on Social Networks: